Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← All stories
Federal PolicyMay 28, 2026

FDA Relaxes Oversight of Blood Pressure Wearables, Raising Clinical Accuracy Concerns

The FDA has relaxed regulatory oversight of wellness wearable devices, allowing blood pressure monitoring technology to enter the market without clinical validation. This policy shift enables consumer devices with unverified accuracy to proliferate, potentially affecting remote patient monitoring programs that Medicaid managed care organizations use for hypertension management and chronic disease monitoring. MCOs relying on wearable data for care management and quality metrics should assess whether their contracted devices meet clinical accuracy standards, particularly for programs serving members with cardiovascular conditions.

Managed Care

Read the full article at statnews.com →
Share this briefing

You might also like

← All stories

Get the daily briefing.